Exploring prostate cancer in the post-genomic era

Chee Wai Chua; Marianna Kruithof-de Julio

doi:10.1016/j.canlet.2022.215992

Exploring prostate cancer in the post-genomic era

Cancer Lett. 2023 Jan 28:553:215992. doi: 10.1016/j.canlet.2022.215992. Epub 2022 Oct 29.

Authors

Chee Wai Chua¹, Marianna Kruithof-de Julio²

Affiliations

¹ State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China. Electronic address: [email protected].
² Department for Biomedical Research, University of Bern, 3008, Bern, Switzerland; Department of Urology, Inselspital, Bern University Hospital, 3010, Bern, Switzerland; Translational Organoid Resource Core, Department for BioMedical Research, University of Bern, 3008, Bern, Switzerland; Bern Center for Precision Medicine, University of Bern, 3010, Bern, Switzerland. Electronic address: [email protected].

PMID: 36397638
DOI: 10.1016/j.canlet.2022.215992

Abstract

In the Special Issue on Prostate Cancer, we have invited 25 researchers or clinicians from prostate cancer community to review the cutting-edge topics in this field. In particular, the mini-reviews have covered various basic science and clinical aspects in prostate cancer, including prostate epithelial stem cells or progenitors, androgen and androgen receptor pathways, tumor modeling, genomics, different cell-autonomous and non-cell-autonomous mechanisms as well as various clinical issues encompassing diagnosis, risk stratification and treatments.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Androgens
Genomics*
Humans
Male
Prostate
Prostatic Neoplasms* / genetics
Prostatic Neoplasms* / therapy
Stem Cells

Substances

Androgens